SESEN BIO INC (SESN) Fundamental Analysis & Valuation

NASDAQ:SESN • US8177631053

Current stock price

0.6288 USD
+0.04 (+7.29%)
At close:
0.5832 USD
-0.05 (-7.25%)
After Hours:

This SESN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. SESN Profitability Analysis

1.1 Basic Checks

  • SESN had negative earnings in the past year.
  • In the past year SESN had a positive cash flow from operations.
SESN Yearly Net Income VS EBIT VS OCF VS FCFSESN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 0 20M -20M -40M -60M -80M -100M

1.2 Ratios

  • The profitability ratios for SESN are negative, so there is not much use analyzing them.
  • Looking at the Return On Invested Capital, with a value of 14.26%, SESN belongs to the top of the industry, outperforming 97.33% of the companies in the same industry.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC 14.26%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SESN Yearly ROA, ROE, ROICSESN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 0 100 -100 200 300 400

1.3 Margins

  • With an excellent Operating Margin value of 49.65%, SESN belongs to the best of the industry, outperforming 98.90% of the companies in the same industry.
  • In the last couple of years the Operating Margin of SESN has grown nicely.
  • The Profit Margin and Gross Margin are not available for SESN so they could not be analyzed.
Industry RankSector Rank
OM 49.65%
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5Y62.37%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SESN Yearly Profit, Operating, Gross MarginsSESN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 0 -2K -4K -6K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. SESN Health Analysis

2.1 Basic Checks

  • SESN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • SESN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
SESN Yearly Shares OutstandingSESN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 50M 100M 150M
SESN Yearly Total Debt VS Total AssetsSESN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 50M 100M 150M 200M

2.2 Solvency

  • Based on the Altman-Z score of 1.65, we must say that SESN is in the distress zone and has some risk of bankruptcy.
  • SESN's Altman-Z score of 1.65 is fine compared to the rest of the industry. SESN outperforms 66.67% of its industry peers.
  • SESN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 1.65
ROIC/WACC1.61
WACC8.88%
SESN Yearly LT Debt VS Equity VS FCFSESN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 0 50M -50M 100M 150M

2.3 Liquidity

  • A Current Ratio of 5.54 indicates that SESN has no problem at all paying its short term obligations.
  • SESN's Current ratio of 5.54 is in line compared to the rest of the industry. SESN outperforms 49.06% of its industry peers.
  • SESN has a Quick Ratio of 5.54. This indicates that SESN is financially healthy and has no problem in meeting its short term obligations.
  • SESN has a Quick ratio (5.54) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 5.54
Quick Ratio 5.54
SESN Yearly Current Assets VS Current LiabilitesSESN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. SESN Growth Analysis

3.1 Past

  • The earnings per share for SESN have decreased strongly by -364.00% in the last year.
  • The Revenue has grown by 816.87% in the past year. This is a very strong growth!
  • Measured over the past years, SESN shows a decrease in Revenue. The Revenue has been decreasing by -2.41% on average per year.
EPS 1Y (TTM)-364%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%455.56%
Revenue 1Y (TTM)816.87%
Revenue growth 3YN/A
Revenue growth 5Y-2.41%
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, SESN will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.42% on average per year.
  • The Revenue is expected to decrease by -14.87% on average over the next years. This is quite bad
EPS Next Y-308%
EPS Next 2Y4.02%
EPS Next 3Y19.21%
EPS Next 5Y12.42%
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5Y-14.87%

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SESN Yearly Revenue VS EstimatesSESN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2020 2021 5M 10M 15M 20M 25M
SESN Yearly EPS VS EstimatesSESN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 -0.5 -1 -1.5

More info and screens

Find the best growth stocksShow best growing peers

2

4. SESN Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for SESN. In the last year negative earnings were reported.
  • Also next year SESN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SESN Price Earnings VS Forward Price EarningsSESN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

  • 97.96% of the companies in the same industry are more expensive than SESN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 13.31
EV/EBITDA -5.23
SESN Per share dataSESN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1

4.3 Compensation for Growth

  • A more expensive valuation may be justified as SESN's earnings are expected to grow with 19.21% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y4.02%
EPS Next 3Y19.21%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. SESN Dividend Analysis

5.1 Amount

  • No dividends for SESN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

SESN Fundamentals: All Metrics, Ratios and Statistics

SESEN BIO INC

NASDAQ:SESN (3/7/2023, 7:50:19 PM)

After market: 0.5832 -0.05 (-7.25%)

0.6288

+0.04 (+7.29%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Industry Strength55.9
Industry Growth13.04
Earnings (Last)02-28
Earnings (Next)05-08
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners1.16%
Ins Owner Change0%
Market Cap127.96M
Revenue(TTM)60.00M
Net Income(TTM)-4.17M
Analysts43.33
Price Target12.24 (1846.56%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)100.94%
Min EPS beat(2)-20.66%
Max EPS beat(2)222.55%
EPS beat(4)3
Avg EPS beat(4)113.84%
Min EPS beat(4)-20.66%
Max EPS beat(4)222.55%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1900%
PT rev (3m)1900%
EPS NQ rev (1m)-1900%
EPS NQ rev (3m)-1900%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.13
P/FCF 13.31
P/OCF 13.31
P/B 0.78
P/tB 0.78
EV/EBITDA -5.23
EPS(TTM)-1.16
EYN/A
EPS(NY)-0.09
Fwd EYN/A
FCF(TTM)0.05
FCFY7.51%
OCF(TTM)0.05
OCFY7.51%
SpS0.29
BVpS0.81
TBVpS0.81
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC 14.26%
ROICexc N/A
ROICexgc N/A
OM 49.65%
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5Y62.22%
OM growth 3YN/A
OM growth 5Y62.37%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.54
Quick Ratio 5.54
Altman-Z 1.65
F-Score4
WACC8.88%
ROIC/WACC1.61
Cap/Depr(3y)25.56%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-364%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%455.56%
EPS Next Y-308%
EPS Next 2Y4.02%
EPS Next 3Y19.21%
EPS Next 5Y12.42%
Revenue 1Y (TTM)816.87%
Revenue growth 3YN/A
Revenue growth 5Y-2.41%
Sales Q2Q%N/A
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5Y-14.87%
EBIT growth 1Y485.82%
EBIT growth 3YN/A
EBIT growth 5Y58.47%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y126.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y126.61%
OCF growth 3YN/A
OCF growth 5YN/A

SESEN BIO INC / SESN Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for SESEN BIO INC?

ChartMill assigns a fundamental rating of 3 / 10 to SESN.


What is the valuation status for SESN stock?

ChartMill assigns a valuation rating of 2 / 10 to SESEN BIO INC (SESN). This can be considered as Overvalued.


Can you provide the profitability details for SESEN BIO INC?

SESEN BIO INC (SESN) has a profitability rating of 1 / 10.


How financially healthy is SESEN BIO INC?

The financial health rating of SESEN BIO INC (SESN) is 5 / 10.